Published in Neuroscience on March 01, 1985
Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (1987) 5.22
Pharmacological characterization of D-aminophosphonovaleric acid antagonism of amino acid and synaptically evoked excitations on frog motoneurones in vitro: an intracellular study. Br J Pharmacol (1985) 0.87
Glutamate in the mammalian CNS. Eur Arch Psychiatry Clin Neurosci (1990) 0.80
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother (1973) 8.83
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother (1982) 6.97
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ (2001) 4.49
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob Agents Chemother (1980) 4.43
Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet (1998) 4.16
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
API ZYM: a simple rapid system for the detection of bacterial enzymes. J Clin Pathol (1977) 3.88
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob Agents Chemother (1980) 3.68
Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother (1976) 3.55
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother (1995) 2.62
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother (1986) 2.59
Anaesthesia of capuchin monkeys. Vet Rec (1994) 2.57
Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (1993) 2.55
Three-dimensional grain mapping by x-ray diffraction contrast tomography and the use of Friedel pairs in diffraction data analysis. Rev Sci Instrum (2009) 2.49
The relationship between chromosome structure and function at a human telomeric region. Nat Genet (1997) 2.48
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother (1986) 2.16
Management of heart disease in the elderly in the Plymouth Health District. J R Coll Physicians Lond (1995) 2.13
Failure to control venereal disease. Br Med J (1970) 2.10
The first Harrison Lecture, 1974. The life and times of Colonel Harrison. Br J Vener Dis (1974) 2.00
The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. J Antimicrob Chemother (1976) 1.96
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother (1985) 1.96
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. J Antimicrob Chemother (2000) 1.95
Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Hum Genet (1986) 1.92
Pharmacological characterization of different types of GABA and glutamate receptors in vertebrates and invertebrates. Prog Neurobiol (1979) 1.89
Evolution of European bat lyssaviruses. J Gen Virol (1997) 1.86
The determinants of health care expenditure: a cointegration approach. J Health Econ (1996) 1.85
A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. Bull World Health Organ (2001) 1.83
The structure and antigenicity of a type C foot-and-mouth disease virus. Structure (1994) 1.82
Comparison of radiometric and gas capture system for blood cultures. J Clin Pathol (1986) 1.81
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol (1997) 1.79
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine (2001) 1.79
Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet (1988) 1.76
Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine (2000) 1.71
Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development (1995) 1.69
GABA receptor mechanisms in the central nervous system. Prog Neurobiol (1991) 1.68
The sensitivity, specificity and predictive values of raised plasma metal ion levels in the diagnosis of adverse reaction to metal debris in symptomatic patients with a metal-on-metal arthroplasty of the hip. J Bone Joint Surg Br (2012) 1.62
Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. J Antimicrob Chemother (1990) 1.57
High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res (1999) 1.55
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. J Antimicrob Chemother (1981) 1.52
Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother (1998) 1.50
Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology (1998) 1.50
Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures. Clin Exp Rheumatol (2007) 1.48
Sperm as a noninvasive gene delivery system for preimplantation embryos. Fertil Steril (1995) 1.48
Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis (1998) 1.47
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother (1984) 1.47
Assessment of middle ear disease in the dog: a comparison of diagnostic imaging modalities. J Small Anim Pract (2007) 1.47
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1982) 1.45
Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol (1998) 1.43
Legal aspects of withdrawal of therapy. Anaesth Intensive Care (2003) 1.42
The first Harrison Lecture 1974. The life and times of Colonel L W Harrison. 1974. Sex Transm Infect (2000) 1.40
Towards the proteome of Mycobacterium tuberculosis. Electrophoresis (2000) 1.39
MIC audit for routine ciprofloxacin sensitivity testing. J Antimicrob Chemother (1993) 1.39
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1981) 1.38
Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology (2011) 1.38
Relationship between hydrocarbon exposure and nephropathology in primary glomerulonephritis. Nephrol Dial Transplant (1994) 1.38
The health of youth. A cross-national survey. WHO Reg Publ Eur Ser (1996) 1.38
The identification of pseudomonads and related bacteria in a clinical laboratory. J Med Microbiol (1978) 1.37
Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol (1997) 1.37
The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod (1999) 1.37
Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother (2004) 1.34
Neutropenic enterocolitis due to Clostridium septicum infection. J Clin Pathol (1984) 1.34
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab (2001) 1.32
Measuring up: results from the National Immunization Coverage Survey, 2002. Can Commun Dis Rep (2004) 1.31
Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada. Am J Trop Med Hyg (1999) 1.30
Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod (2000) 1.30
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol (1997) 1.29
The peripheral parasympathetic innervation of the cat lacrimal gland. Br J Pharmacol (1970) 1.24
Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure (1996) 1.24
Detection of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol (1998) 1.23
Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis (2008) 1.22
Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther (2001) 1.22
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg (2005) 1.21
A comparative study of the action of gamma-aminobutyric acid and piperazine on the lobster muscle fibre and the frog spinal cord. Br J Pharmacol (1976) 1.21
Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. EMBO J (1997) 1.20
Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens (1997) 1.19
Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology (2000) 1.17
Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamases. J Antimicrob Chemother (1982) 1.17
A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med (1990) 1.17
Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis. Hum Genet (1986) 1.17
Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections. J Antimicrob Chemother (1983) 1.17
Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme. J Biol Chem (1999) 1.15
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15. FEMS Microbiol Lett (1990) 1.14
Spontaneous rhythmic bursts induced by pharmacological block of inhibition in lumbar motoneurons of the neonatal rat spinal cord. J Neurophysiol (1996) 1.14
Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol (1994) 1.13
Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med (1997) 1.13
Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol (2002) 1.13
Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens (1999) 1.12
A taxonomic study of clinical isolates of Pseudomonas pickettii, 'P. thomasii' and 'group IVd' bacteria. J Gen Microbiol (1979) 1.12
Fluconazole disc diffusion testing for the routine laboratory. J Antimicrob Chemother (1997) 1.11
Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129. Neurology (2007) 1.11